Maximus (NYSE:MMS) Stock Rating Upgraded by StockNews.com

Maximus (NYSE:MMS) was upgraded by research analysts at StockNews.com from a “hold” rating to a “buy” rating in a report issued on Wednesday.

Separately, Raymond James raised shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price objective for the company in a research report on Thursday, January 2nd.

Maximus Stock Performance

Shares of MMS traded down $1.59 on Wednesday, reaching $75.37. The company’s stock had a trading volume of 755,994 shares, compared to its average volume of 608,139. The stock’s 50 day simple moving average is $74.64 and its two-hundred day simple moving average is $84.15. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.49 and a quick ratio of 1.49. The stock has a market capitalization of $4.54 billion, a P/E ratio of 15.07 and a beta of 0.73. Maximus has a 12-month low of $69.72 and a 12-month high of $93.97.

Insider Activity at Maximus

In other Maximus news, CEO Bruce Caswell acquired 3,500 shares of the stock in a transaction dated Tuesday, December 17th. The shares were acquired at an average cost of $70.64 per share, for a total transaction of $247,240.00. Following the completion of the transaction, the chief executive officer now directly owns 275,929 shares of the company’s stock, valued at approximately $19,491,624.56. The trade was a 1.28 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Raymond B. Ruddy acquired 3,490 shares of the company’s stock in a transaction dated Thursday, December 12th. The stock was acquired at an average cost of $71.46 per share, with a total value of $249,395.40. Following the purchase, the director now owns 112,520 shares of the company’s stock, valued at approximately $8,040,679.20. This trade represents a 3.20 % increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last ninety days, insiders purchased 7,063 shares of company stock worth $502,017. 1.40% of the stock is owned by company insiders.

Hedge Funds Weigh In On Maximus

Several institutional investors have recently bought and sold shares of the stock. V Square Quantitative Management LLC purchased a new stake in Maximus in the 3rd quarter worth $25,000. UMB Bank n.a. increased its holdings in shares of Maximus by 79.8% in the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after purchasing an additional 158 shares during the last quarter. Eastern Bank purchased a new stake in shares of Maximus in the fourth quarter worth about $29,000. R Squared Ltd bought a new position in Maximus during the fourth quarter valued at approximately $54,000. Finally, GAMMA Investing LLC boosted its stake in Maximus by 150.6% during the third quarter. GAMMA Investing LLC now owns 862 shares of the health services provider’s stock valued at $80,000 after buying an additional 518 shares during the last quarter. 97.21% of the stock is owned by hedge funds and other institutional investors.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.